Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
MTHERA PHARMA logo — company profile

MTHERA PHARMA

Founded 2020 Korea South Korea South 8 employees Venture round Total: $3.50B Biotechnology, Pharmaceutical

General Information

Company Name MTHERA PHARMA
Founded Year 2020
Location Korea South Korea South
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with MTHERA PHARMA. To contact MTHERA PHARMA, visit mtherapharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MTHERA PHARMA compare?

A PDF of MTHERA PHARMA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MTHERA PHARMA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MTHERA PHARMA

MThera Pharma Co., Ltd. is a biopharmaceutical company founded in 2020 in South Korea. The company is focused on developing novel multi-component/multi-target driven, disease-modifying therapies for chronic incurable diseases. MThera has established the platform technology, SyMthomics, which consists of the MThera-CODA system, an AI-based in silico system, the most cutting-edge multi-omics integration technology, systems biology, and bioinformatics. Additionally, MThera has set up standardization technology and advanced CMC technology for raw materials, drug substances, and drug products to meet the US FDA requirement for therapeutic consistency and totality of the evidence. The company is pioneering first-in-class botanical drug products to deal with diverse etiologies and treat chronic incurable diseases like Parkinson's disease and Inflammatory bowel disease. The last investment, a Venture Round investment at 08 August 2022, was made by Korea Venture Investment Corp. MThera Pharma operates within the Biotechnology and Pharmaceutical industries.

Business keywords: Biopharmaceutical, Drug development, Multi-target therapy, SyMthomics platform, AI-based in silico system, Multi-omics integration, Systems biology, Bioinformatics, Standardization technology, CMC technology, Botanical drug products, Therapeutic consistency, Parkinson's disease, Inflammatory bowel disease, FDA requirements

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Korea Venture Investment Corp
Korea Venture Investment Corp
08 Aug 2022
Series B Undisclosed 5
DAYLI Partners IBK Capital Genaxis
DAYLI Partners, IBK Capital +3
24 Dec 2021
Series A KRW3.20B 3
DAYLI Partners Sejong Venture Partners Tony Investment
DAYLI Partners, Sejong Venture Partners +1
07 Apr 2021
Seed Round Undisclosed 2
Woori Technology Investment
Woori Technology Investment, Daepyung
28 Dec 2020
Seed Round Undisclosed 2
Huons
Huons, TIPS Program
04 Jul 2020
Angel Round KRW300.00M 1
DAYLI Partners
DAYLI Partners
06 Mar 2020

MTHERA PHARMA Alternatives & Competitors

View All Alternatives
MTHERA PHARMA vs
MedBiome
MedBiome Canada

Targeting the microbiome to improve human health

1 employees
Biotechnology, Pharmaceutical
MTHERA PHARMA vs
Hillhurst Biopharmaceuticals, Inc.
Hillhurst Biopharmaceuticals, Inc.

Unlocking the potential of therapeutic gasses through novel liquid medicines

Seed
10 employees
Biotechnology, Health and Wellness
MTHERA PHARMA vs
Inspirna, Inc.
Inspirna, Inc. United States

Converting cancer to a manageable, chronic condition

Series D
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About MTHERA PHARMA

MThera Pharma Co., Ltd. is a biopharmaceutical company focused on developing novel multi-component/multi-target driven, disease-modifying therapies for chronic incurable diseases. MThera has established platform technology, SyMthomics consists of MThera-CODA system (AI based in silico system), the m...
MTHERA PHARMA was founded in 2020.
MTHERA PHARMA is headquartered in Korea South.
MTHERA PHARMA operates in Biotechnology and Pharmaceutical. Its work centres on Biopharmaceutical, Drug development, Multi-target therapy and SyMthomics platform.
MTHERA PHARMA has approximately 8 employees.
MTHERA PHARMA has completed 6 funding rounds, raising a total of $3.50B. The latest funding stage is Venture round.
Top alternatives and competitors to MTHERA PHARMA include MedBiome, Hillhurst Biopharmaceuticals, Inc., Inspirna, Inc., Enable Medicine, Quince Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MTHERA PHARMA and MedBiome are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MTHERA PHARMA, https://bouncewatch.com/company/mthera-pharma, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes